Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis
Completed · Phase 2
Conditions studied: Ulcerative Colitis, Gastrointestinal Disease, Inflammatory Bowel Disease
In brief
The purpose of The PROSPECT Study is to evaluate an investigational medication for the treatment of moderate to severe ulcerative colitis. This study is being conducted at up to 38 clinical research centers in the US, Canada, and Belgium, and is open to male and female patients 12 years and older. Participants in the study will have a number of visits to a research center over a five-month period. All study related care and medication is provided to qualified participants at no cost: this includes all visits, examinations, and laboratory work.
Key facts
- Study ID
- NCT00073047
- Run by
- Facet Biotech
- People needed
- 150
- Starts
- 2003-04-01
- Expected to finish
- 2006-07-01
- Last updated by the study team
- 2009-07-20
Who can join
Age: 12 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Clinical Research Associates — Huntsville, Alabama, United States
- Advanced Medical Research Institute — Anaheim, California, United States
- Research Foundation of America — Los Angeles, California, United States
- Western Gastroenterology Group — Los Angeles, California, United States
- Cedar Sinai Medical Center — Los Angeles, California, United States
- GVAMC — Gainesville, Florida, United States
- Clinical Research Associates — Hollywood, Florida, United States
- Physician Office — Jacksonville, Florida, United States
- Mount Sinai Medical Center — North Miami Beach, Florida, United States
- Atlanta Gastroenterology Associates — Atlanta, Georgia, United States
- The University of Chicago Hospital — Chicago, Illinois, United States
- University of Kentucky Chandler Medical Center — Lexington, Kentucky, United States
- Drug Research Services, Inc. — Metairie, Louisiana, United States
- Medlantic Investigators Network — Annapolis, Maryland, United States
- St. Louis Center for Clinical Research — St Louis, Missouri, United States
- Long Island Clinical Research Associates — Great Neck, New York, United States
- New York Center for Clinical Research — Lake Success, New York, United States
- University of North Carolina — Chapel Hill, North Carolina, United States
- Consultants for Clinical Research — Cincinnati, Ohio, United States
- Cleveland Clinic Foundation — Cleveland, Ohio, United States
- Oklahoma Foundation for Digestive Research — Oklahoma City, Oklahoma, United States
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
- Columbia Gastro Associates — Columbia, South Carolina, United States
- Memphis Gastroenterology Group, P.C. — Memphis, Tennessee, United States
- Nashville Medical Research — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.